Mini-symposia

The mini-symposia are where you go for the most complete look at a broad range of topics pertinent to students of controlled release and delivery. CRS is hosting six mini-symposia and has invited the following speakers to present in Portland.

Theranostics: Diagnosis and Treatment in One Box

In vivo Transport of Polymeric Micelles at the Whole Body, Tumor, and Cellular Levels, Christine Allen, University of Toronto, Canada
Designed Fabrication and Assembly of Uniform-Sized Nanoparticles for Multifunctional Biomedical Applications, Taeghwan Hyeon, Seoul National University, Korea
Magnetic microbubbles for multimodality imaging and targeted therapy, Eleanor Stride, University College, U.K.
Multifunctional Nanoparticles for Optical Imaging, Ick Chan Kwon, KIST, Korea

Stem Cells--Yes, We Can!

Co-cultures, 3D scaffolds and local stimulations for controlled differentiation and organization of embryonic stem cells, Shulamit Levenberg, TECHNION Israel Institute of Technology, Israel
Controlling Angiogenic Factor Regulation by Utilising a 3D Collagen Model and Hypoxia-Induced Signalling,Umber Cheema, University College London, U.K.
Stem Cells--Yes, We Can!, Jennifer Elisseeff, Johns Hopkins University, U.S.A.
Using drug delivery systems to build 3D structures for regenerative medicine applications, Kevin Shakesheff, University of Nottingham, U.K.

Lipid Nanoparticle-Based Delivery of RNAi Therapeutics, Akin Akinc, Alnylam Pharmaceuticals, U.S.A.
Targeted Polymer Nanoparticles for RNA Based Cancer Therapy, Ernst Wagner, Munich Center for System-based Drug Research Center for Nanoscience, Ludwig-Maximilians-Universität, Munich, Germany
Design of Lipid Nanoparticles for Systemic Delivery of siRNA, , Pieter Cullis, University of British Columbia, Canada
Dynamic Membrane-Active Polymers for SiRNA Delivery in Vivo, Jon Wolff, Roche, U.S.A.

Vaginal Drug Delivery: Past, Present, and Future

Intravaginal Rings: Contraceptives, Proteins and Microbicides, David Friend, CONRAD, U.S.A.
Environmentally Responsive Delivery Systems for the Vagina, Patrick Kiser, University of Utah, U.S.A.
Development of Mucoadhesive Formulations for Vaginal Delivery of Nitric Oxide, Chi H. Lee, University of Missouri, U.S.A.
Topical microbicides to prevent the transmission of HIV: formulation and delivery challenges and opportunities, Jim Turpin, NIH/NIAID/DAIDS, U.S.A.

Biomarkers: The Needle in the Haystack

The Importance of Leveraging Biomarkers and Pharmacokinetic (PK) and Pharmacodynamic (PD) Knowledge in Early Clinical Drug Development, Ene Ette, Anoixis Corp., U.S.A.
Molecular Signature Specific Targeting Peptides for Drug Delivery and Imaging, In-San Kim, Kyungpook National University, Korea
Discovery of Protein Biomarkers for Diagnosis and Treatment of Alzheimer's Disease, Kelvin Lee, University of Delaware, U.S.A

Biomedical Photonics: In vivo Diagnostics of Malignancy with Targeted Delivery Tools

Novel platforms for optical detection of cancerous biomarkers in the lumen of the GI tract, Avri Rubinstein, Hebrew University of Jerusalem, Israel
Molecular probes and miniature microscopes for detection of GI cancers, Christopher Contag, Stanford University, U.S.A.
Activatable Strategies for Fluorescent Probe Design in the Molecular Imaging, Hisataka Kobayashi, NIH Clinical Center, U.S.A.
Polyp-specific contrast agents for virtual colonoscopy: Rationale and early developments, Ron Summers, NIH Clinical Center, U.S.A.